Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite has four ANDA products partnered with TAGI Pharma; one ANDA has launched, two ANDAs are in the process of a manufacturing site transfer and an additional ANDA is currently under review by the FDA. Elite also manufactures Lodrane D® and receives royalties for Lodrane D®, an allergy product partnered with ECR Pharmaceuticals (“ECR”), a wholly owned subsidiary of Hi-Tech Pharmacal (“Hi-Tech”). Elite’s lead pipeline products, ELI-216, a once-daily abuse resistant oxycodone, and ELI-154, a once-daily oxycodone, are novel sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also has partnered with Mikah Pharma to develop a new product and with Hi-Tech Pharmacal to develop an intermediate for a generic product. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.
View Top Employees from Elite Pharmaceuticals, Inc.Website | http://www.elitepharma.com |
Ticker | ELTP |
Revenue | $7 million |
Funding | $42.2 million |
Employees | 56 (56 on RocketReach) |
Founded | 1996 |
Address | 165 Ludlow Ave, Northvale, New Jersey 07647, US |
Phone | (201) 750-2646 |
Fax | (201) 750-2755 |
Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Biotechnology, Specialty Pharmaceuticals, Retail, Science and Engineering, Controlled Release Drug Products, Medical, Extended Release Drug Products, Health Care, Generic Drugs, Pharmaceutical, Contract Manufacturing |
Web Rank | 4 Million |
Keywords | Elite Laboratories, Elite Pharmaceuticals, Elite Pharma, Elitepharm, Elite Pharms Inc |
Competitors | Chiesi USA, Inc., Critical Pharmaceuticals Ltd., Depomed, Inc., Intellipharmaceutics International, Sanochemia Pharmazeutika |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Elite Pharmaceuticals, Inc. employee's phone or email?
The Elite Pharmaceuticals, Inc. annual revenue was $7 million in 2024.
56 people are employed at Elite Pharmaceuticals, Inc..
Elite Pharmaceuticals, Inc. is based in Northvale, New Jersey.
The NAICS codes for Elite Pharmaceuticals, Inc. are [32541, 3254, 325, 32].
The SIC codes for Elite Pharmaceuticals, Inc. are [28, 283].